Despite the incomplete foci clearance by LshCas13a, the CUG-targeting LshCas13a was sufficient to yield a reversal of splicing defects in six MBNL1-regulated genes that are known to contribute to DM1 phenotype (Figure 3A). The gene discussed is MBNL1; the disease is myotonic dystrophy type 1.